ReviewDrug discovery today. Technologies2021

Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches.

Amrita Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.